JPMorgan Chase & Co. set a €59.60 ($69.30) price objective on Gerresheimer (ETR:GXI) in a research note published on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
Several other equities research analysts have also recently issued reports on GXI. Deutsche Bank set a €80.00 ($93.02) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Wednesday, November 20th. Independent Research set a €69.00 ($80.23) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research report on Tuesday, November 26th. Berenberg Bank set a €81.00 ($94.19) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Wednesday, November 20th. Goldman Sachs Group set a €84.00 ($97.67) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Monday, February 10th. Finally, HSBC set a €85.00 ($98.84) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Monday, October 14th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. Gerresheimer presently has a consensus rating of Hold and a consensus target price of €73.07 ($84.96).
Gerresheimer stock opened at €71.55 ($83.20) on Tuesday. The stock has a market cap of $2.25 billion and a P/E ratio of 10.85. The company has a fifty day simple moving average of €69.13 and a 200-day simple moving average of €68.36. Gerresheimer has a 12-month low of €56.50 ($65.70) and a 12-month high of €74.80 ($86.98). The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 65.99.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Recommended Story: Bond
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.